Sodium Hydroxide → 5-[3-(3,4-Dihydro-5-isoquinolinyl)-1,2,4-oxadiazol-5-yl]-2-[(1-methylethyl)oxy]benzonitrile

HRID 2383302Notes

Reaction equation

HRID 2383302 reaction equation
[CH3:1][CH:2]([O:4][C:5]1[CH:12]=[CH:11][C:10]([C:13]2[O:17][N:16]=[C:15]([C:18]3[CH:27]=[CH:26][CH:25]=[C:24]4[C:19]=3[CH2:20][CH2:21][NH:22][CH2:23]4)[N:14]=2)=[CH:9][C:6]=1[C:7]#[N:8])[CH3:3].BrN1C(=O)CCC1=O.[OH-].[Na+]>C(Cl)Cl>[CH:23]1[C:24]2[C:19](=[C:18]([C:15]3[N:14]=[C:13]([C:10]4[CH:11]=[CH:12][C:5]([O:4][CH:2]([CH3:3])[CH3:1])=[C:6]([CH:9]=4)[C:7]#[N:8])[O:17][N:16]=3)[CH:27]=[CH:26][CH:25]=2)[CH2:20][CH2:21][N:22]=1

Participants

5

Procedure

A solution of 2-[(1-methylethyl)oxy]-5-[3-(1,2,3,4-tetrahydro-5-isoquinolinyl)-1,2,4-oxadiazol-5-yl]benzonitrile (Preparation 7, 50 mg, 0.139 mmol) and N-bromosuccinimide (29.6 mg, 0.166 mmol) in DCM (5 mL) was heated at reflux for 3 h, then cooled to room temperature. 2M aqueous NaOH (5 mL) was added, and the layers separated. The aqueous was extracted with DCM (5 mL) and the organic layers combined. Concentration in vacuo gave the title compound as a yellow solid (47.8 mg). 1H NMR (400 MHz, CDCl3) δ 8.52 (1H, t), 8.43 (1H, d), 8.34 (1H, dd), 8.23 (1H, dd), 7.55-7.51 (2H, m), 7.14 (1H, d), 4.81 (1H, sept), 3.86 (2H, td), 3.31 (2H, t), 1.48 (6H, d); m/z (ES) 359 [M+H]+.

Workup

  1. temperatureat reflux for 3 h
  2. customthe layers separated
  3. extractionThe aqueous was extracted with DCM (5 mL)
  4. concentrationConcentration in vacuo

Sources & evidence

ORD record
ord-06c8d64399604a5aa07ce0d115f155f8
Source dataset
uspto-grants-2012_09
Patent number
US08263620B2

Reaction notes

Loading…